Most material SEC filings — August 26, 2026

On 2026-08-25, Avalanche Treasury Corp filed an 8-K disclosing Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific counterparties, dollar amounts, percentages, share counts, or detailed reasons for the delisting notice are disclosed in the filing header or document metadata provided. The filing indicates a material adverse listing event but lacks concrete operational or financial specifics.

Avalanche Treasury Corp (AVAT), a $2.2M-asset company that completed its Nasdaq IPO on June 11, 2026, reported a Q2 2026 net loss of $44.7M ($1.54/share), of which $35.7M (80%) was attributable to AVAX fair-value declines and $15.2M to one-time business-combination costs. The company holds 15.3M AVAX ($100M carrying value at quarter-end) and generated $1.5M in staking revenue in Q2 (net of fees). The Board approved a $10M class A share repurchase program. Core G&A expenses were $3.5M.

SK Biopharmaceuticals Co., Ltd. (SKBP) and Biohaven Bioscience Ireland Limited entered into an exclusive license agreement dated August 26, 2026, for worldwide rights to develop, manufacture, and commercialize Kv7 activators, including BHV-7000 (opakalim), in all indications. SKBP will pay Biohaven $400M upfront ($350M at closing, $50M at 1-year), up to $150M in regulatory milestones, tiered royalties on net sales (reduced for generics/price controls), and assume Knopp Biosciences obligations (~$245M in milestones plus running royalties). Closing is subject to antitrust clearance and other conditions.

Target Hospitality announced a new multi-year contract with a top-five hyperscaler to provide modular accommodations and hospitality services for a data center project in West Texas, expected to generate approximately $250 million in revenue through August 2030 and support ~1,100 individuals. The company will modify existing under-utilized assets requiring less than $15 million capital investment, enabling third-quarter 2026 occupancy. Target raised full-year 2026 guidance: revenue to $435–445M (6% midpoint increase) and Adjusted EBITDA to $105–115M (22% midpoint increase), and projects annualized revenue exceeding $750M and Adjusted EBITDA above $300M exiting 2027.

On 08/18/2026, Senmiao Technology Limited filed a Certificate of Amendment to its Articles of Incorporation with the Nevada Secretary of State (Filing #20265976248), effective 08/25/2026. Officer Ronggang Zhang authorized the amendment. Prior to this, on 08/04/2026, Senmiao reserved the name 'Valor Energy Inc.' for 90 days (expiring 11/02/2026, Filing #20265946380). The specific substantive amendments to articles are not detailed in the filing; the checkbox marked indicates 'The authorized shares have been amended,' but no share counts, dollar amounts, or detailed terms are disclosed.

Dycom reported Q2 FY2027 record contract revenues of $2.006B (45.6% YoY growth, 16.7% organic), with adjusted EBITDA of $315.5M (15.7% margin) and adjusted diluted EPS of $5.29. The company completed its acquisition of National Technology Integrators (~$22.9M Q2 revenue contribution) and raised full-year FY2027 revenue guidance to $7.48–$7.66B (from prior guidance). Total backlog reached a record $12.242B (+53.2% YoY), with $6.472B in next-12-months backlog. Communications segment revenues of $1.608B grew 16.7% organically; Building Systems (now reported separately post-NTI acquisition) contributed $397.5M with 24.5% adjusted EBITDA margin.